Free Trial
NASDAQ:BWAY

Brainsway (BWAY) Stock Price, News & Analysis

Brainsway logo
$13.15 +0.35 (+2.73%)
As of 07/3/2025 02:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Brainsway Stock (NASDAQ:BWAY)

Key Stats

Today's Range
$12.88
$13.25
50-Day Range
$8.61
$13.22
52-Week Range
$5.67
$13.35
Volume
33,240 shs
Average Volume
67,672 shs
Market Capitalization
$248.54 million
P/E Ratio
65.75
Dividend Yield
N/A
Price Target
$14.25
Consensus Rating
Buy

Company Overview

Brainsway Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

BWAY MarketRank™: 

Brainsway scored higher than 28% of companies evaluated by MarketBeat, and ranked 2404th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Brainsway has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Brainsway has only been the subject of 1 research reports in the past 90 days.

  • Read more about Brainsway's stock forecast and price target.
  • Earnings Growth

    Earnings for Brainsway are expected to grow by 100.00% in the coming year, from $0.08 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Brainsway is 65.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.53.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Brainsway is 65.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.40.

  • Price to Book Value per Share Ratio

    Brainsway has a P/B Ratio of 3.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Brainsway's valuation and earnings.
  • Percentage of Shares Shorted

    0.82% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently increased by 21.41%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Brainsway does not currently pay a dividend.

  • Dividend Growth

    Brainsway does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.82% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently increased by 21.41%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Brainsway has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • MarketBeat Follows

    1 people have added Brainsway to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Brainsway insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Brainsway is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.11% of the stock of Brainsway is held by institutions.

  • Read more about Brainsway's insider trading history.
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brainsway and its competitors with MarketBeat's FREE daily newsletter.

BWAY Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Brainsway Ltd. ADR
See More Headlines

BWAY Stock Analysis - Frequently Asked Questions

Brainsway's stock was trading at $9.43 at the beginning of the year. Since then, BWAY shares have increased by 39.4% and is now trading at $13.15.

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) issued its quarterly earnings results on Tuesday, May, 13th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.02. The company earned $11.54 million during the quarter, compared to analyst estimates of $11.45 million. Brainsway had a net margin of 9.01% and a trailing twelve-month return on equity of 7.35%.
Read the conference call transcript
.

Brainsway (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brainsway investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP).

Company Calendar

Last Earnings
5/13/2025
Today
7/04/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BWAY
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$14.25
High Stock Price Target
$16.00
Low Stock Price Target
$12.50
Potential Upside/Downside
+8.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
65.75
Forward P/E Ratio
164.38
P/E Growth
N/A
Net Income
$2.92 million
Pretax Margin
10.22%

Debt

Sales & Book Value

Annual Sales
$41.02 million
Cash Flow
$0.26 per share
Price / Cash Flow
51.33
Book Value
$3.31 per share
Price / Book
3.97

Miscellaneous

Free Float
15,305,000
Market Cap
$248.54 million
Optionable
Not Optionable
Beta
1.40
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BWAY) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners